2.12
0.01 (0.47%)
| Previous Close | 2.11 |
| Open | 2.11 |
| Volume | 46,600 |
| Avg. Volume (3M) | 140,586 |
| Market Cap | 2,796,979,456 |
| Price / Earnings (TTM) | 5.44 |
| Price / Sales | 2.02 |
| Price / Book | 1.65 |
| 52 Weeks Range | |
| Earnings Date | 28 Mar 2025 |
| TTM Dividend Yield | 52.24% |
| Profit Margin | 33.20% |
| Operating Margin (TTM) | 27.05% |
| Diluted EPS (TTM) | 0.400 |
| Quarterly Revenue Growth (YOY) | -30.20% |
| Quarterly Earnings Growth (YOY) | -3.40% |
| Total Debt/Equity (MRQ) | 0.96% |
| Current Ratio (MRQ) | 2.00 |
| Operating Cash Flow (TTM) | 1.37 B |
| Levered Free Cash Flow (TTM) | 1.84 B |
| Return on Assets (TTM) | 4.79% |
| Return on Equity (TTM) | 29.65% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (SG) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | TJ DaRenTang USD | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -0.25 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| TJ DARENTANG USD | 3 B | 52.24% | 5.44 | 1.65 |
| IX BIOPHARMA | 16 M | - | - | 4.30 |
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Mid Value |
| % Held by Insiders | 8.85% |
| % Held by Institutions | 0.15% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Tianjin Pharmaceutical Holdings Ltd. | 30 Jun 2024 | 325,855,528 (57.15%) |
| Beijing Yuanfeng Private Equity Fund Management Partnership (L.P.) | 30 Jun 2024 | 3,607,938 (0.63%) |
| First Seafront Fund Management Co., Ltd. | 30 Jun 2024 | 2,549,078 (0.45%) |
| China Universal Asset Management Co., Ltd. | 30 Jun 2024 | 2,025,715 (0.36%) |
No data within this time range.
No data within this time range.
| TTM Dividend Yield | 52.24% |
| Payout Ratio | 44.23% |
| Expected Next Dividend Payment | Jul 2026 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 02 Jul 2024 | 25 Jun 2024 | 12 Jul 2024 | CNY 1.28 Cash |
| 26 May 2023 | 19 May 2023 | 06 Jun 2023 | CNY 1.12 Cash |
| 24 May 2022 | 17 May 2022 | 02 Jun 2022 | CNY 0.5 Cash |
| 15 Jun 2021 | 08 Jun 2021 | 24 Jun 2021 | CNY 0.3 Cash |
| 15 Jun 2020 | 08 Jun 2020 | 24 Jun 2020 | CNY 0.3 Cash |
| 01 Jul 2019 | 24 Jun 2019 | 15 Jul 2019 | CNY 0.22 Cash |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |